Cost consequences of the 340B drug discount program
- PMID: 23609758
- PMCID: PMC4036617
- DOI: 10.1001/jama.2013.4156
Cost consequences of the 340B drug discount program
Conflict of interest statement
Comment in
-
Drug discount program.JAMA. 2013 Oct 16;310(15):1626-7. doi: 10.1001/jama.2013.276737. JAMA. 2013. PMID: 24129471 No abstract available.
-
Drug discount program.JAMA. 2013 Oct 16;310(15):1626. doi: 10.1001/jama.2013.276758. JAMA. 2013. PMID: 24129472 No abstract available.
-
Drug discount program--reply.JAMA. 2013 Oct 16;310(15):1627. doi: 10.1001/jama.2013.276770. JAMA. 2013. PMID: 24129474 No abstract available.
References
-
- Public Health Service Act, §340B, 42 USC. Health Resources and Services Administration; [Accessed March 2013]. website. http://www.hrsa.gov/opa/programrequirements/phsactsection340b.pdf.
-
- Manufacturer Discounts in the 340B Program Offer Benefits, but Federal Oversight Needs Improvement (GAO-11-836) Washington, DC: US Government Accounting Office; 2011.
-
- Centers BJ. Apexus Inc 340B pricing [PowerPoint presentation]. Presented at 340B University conference; March 11, 2013; Baltimore, MD.
-
- Pollack A. Dispute develops over drug discount program. [Accessed February 2013];New York Times. 2013 Feb 12; http://www.nytimes.com/2013/02/13/business/dispute-develops-over-340b-di....
-
- Taylor M. Finance. New Medicare cuts will force hospitals to plug major revenue leak. Hosp Health Netw. 2010;84(9):12, 14. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
